Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion

NCT04664725 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer Patients

Interventions

DRUG: Repaglinide, Bupropion and SHR3680

Sponsor

Jiangsu HengRui Medicine Co., Ltd.